Thomas F. Goss
- Molecular Medicine top 0.5%
-
- Antibiotic Use and Resistance 4
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy 8
- Clinical Biochemistry top 2%
- Transplantation top 5%
-
- Health Systems, Economic Evaluations, Quality of Life 8
-
- Hepatitis C virus research 6
-
- Pelvic floor disorders treatments 5
-
- Pneumonia and Respiratory Infections 5
- Liver Disease Diagnosis and Treatment 5
-
- Potassium and Related Disorders 4
- Co-authors
- Jerome J. SchentagDavid E. NixMary C. BirminghamAlan ForrestCharles H. BallowCharles F. ShieldDavid A. BuchnerJohn E. Ware
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Thomas F. Goss
64 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Molecular Medicine 562
- Applied Microbiology and Biotechnology 198
- Pharmacology 993
- Clinical Biochemistry 184
- Transplantation 63
Countries citing papers authored by Thomas F. Goss
This map shows the geographic impact of Thomas F. Goss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Goss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Goss more than expected).
Fields of papers citing papers by Thomas F. Goss
This network shows the impact of papers produced by Thomas F. Goss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Goss. The network helps show where Thomas F. Goss may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas F. Goss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 2 | |
| 5 | 2020 | 1 | |
| 6 | 2016 | 6 | |
| 7 | 2013 | 38 | |
| 8 | 2012 | 1 | |
| 9 | 2010 | 4 | |
| 10 | 2009 | 42 | |
| 11 | 2008 | 23 | |
| 12 | Clinical Characteristics and Impact of Neovascular Age–Related Macular Degeneration on Medical Status, Daily Living, Functioning, and Health Resource Utilization: A Survey of Five Countries | 2006 | 2 |
| 13 | Humanistic Burden and Health Resource Utilization Among Neovascular Age–Related Macular Degeneration (AMD) Patients: Results from a Multi–Country Cross–Sectional Study | 2006 | 1 |
| 14 | 2002 | 28 | |
| 15 | 2002 | 4 | |
| 16 | 2001 | 7 | |
| 17 | 2000 | 81 | |
| 18 | 1994 | 1 | |
| 19 | 1992 | 15 | |
| 20 | 1992 | 10 |
About Thomas F. Goss
Thomas F. Goss is a scholar working on Applied Microbiology and Biotechnology, Hepatology and Transplantation, having authored 68 papers that have together received 2.2k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Hepatitis C virus research (6 papers), Pelvic floor disorders treatments (5 papers), Pneumonia and Respiratory Infections (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Potassium and Related Disorders (4 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Molecular Medicine (562 citations), Applied Microbiology and Biotechnology (198 citations) and Pharmacology (993 citations). Thomas F. Goss has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jerome J. Schentag, David E. Nix, Mary C. Birmingham, Alan Forrest, Charles H. Ballow, Charles F. Shield, David A. Buchner, John E. Ware, Martha Bayliss and Deborah Buchner. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.